{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:53:33Z","timestamp":1781636013322,"version":"3.54.5"},"reference-count":16,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/10826084.2025.2604213","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:47:17Z","timestamp":1765975637000},"page":"1301-1303","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Ibogaine: Revisiting an Ancient Alkaloid for Modern Opioid Dependence"],"prefix":"10.1080","volume":"61","author":[{"given":"Markus D.","family":"Moore","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Texas Health Harris Methodist Hospital Fort Worth","place":["Fort Worth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryann K.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Behavioral Health, John Peter Smith Hospital","place":["Fort Worth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed K.","family":"Alzghari","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Texas Health Harris Methodist Hospital Fort Worth","place":["Fort Worth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-9598(01)56018-6"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2007.08.034"},{"key":"e_1_3_2_4_1","article-title":"Ibogaine to determine maximum tolerated dose or treat-to-target dose for the evaluation of efficacy and safety","author":"Atai Therapeutics, Inc","year":"2024","unstructured":"Atai Therapeutics, Inc. (2024). Ibogaine to determine maximum tolerated dose or treat-to-target dose for the evaluation of efficacy and safety. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05029401","journal-title":"ClinicalTrials.gov"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2010.00251.x"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02705-w"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1556\/2054.01.2017.009"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2017.1287372"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41557-024-01714-7"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15448"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63487"},{"key":"e_1_3_2_12_1","unstructured":"Office of the Texas Governor. (2025). Governor Abbott signs ibogaine treatment research law at Texas Capitol. https:\/\/gov.texas.gov\/news\/post\/governor-abbott-signs- ibogaine-treatment-research-law-at-texas-capitol"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231200882"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41285-025-00220-1"},{"key":"e_1_3_2_15_1","unstructured":"U.S. Food and Drug Administration. (2022). Sublocade (buprenorphine extended-release) injection Prescribing Information. FDA Package Insert - Sublocade. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/209819s020lbl.pdf"},{"key":"e_1_3_2_16_1","unstructured":"U.S. Food and Drug Adminstration. (2016). Methadone hydrochloride injection USP - accessdata.fda.gov. FDA Package Insert - Methadone Injection. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/021624s006lbl.pdf"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2025.100213"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2025.2604213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:04:05Z","timestamp":1781633045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2025.2604213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/10826084.2025.2604213"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2025.2604213","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}